Dividend compounder review

ORKA

Oruka Therapeutics, Inc. · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score33.05/100
Confidence82.00/100
DecisionReject
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 2.5 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 10.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 6.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 2.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 12.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years1
Dividend Yield27.69%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$-105.4M
Free Cash Flow$-88.4M
FCF Covers DividendNo
Debt / Equity0.37
P/E-
Revenue Growth 5Y-
Net Margin0.0%
ROE-27.3%
Price vs Trend58.9%
3Y Return430.8%
5Y Return199.1%
CurrencyUSD
Warnings

Review flags

Dividend history is short: 1 completed years.
Free cash flow is negative.
Free cash flow does not cover dividends paid.
Dividend yield is unusually high at 27.7%; possible value trap.
Dividend diary

Activity record

ORKA dividend review warning Warning · Warning

Dividend yield is unusually high at 27.7%; possible value trap.

ORKA dividend payment 19.36 USD Dividend Payment · Info

Recorded dividend payment for Oruka Therapeutics, Inc..